Related Experiment Video
Updated: Jan 6, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Viral N6-methyladenosine upregulates replication and pathogenesis of human respiratory syncytial virus
Miaoge Xue1, Boxuan Simen Zhao2, Zijie Zhang2
1Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH, 43210, USA.
Abstract:
N6-methyladenosine (m6A) is the most prevalent internal modification of mRNAs in most eukaryotes. Here we show that RNAs of human respiratory syncytial virus (RSV) are modified by m6A within discreet regions and that these modifications enhance viral replication and pathogenesis. Knockdown of m6A methyltransferases decreases RSV replication and gene expression whereas knockdown of m6A demethylases has the opposite effect. The G gene transcript contains the most m6A modifications. Recombinant RSV variants expressing G transcripts that lack particular clusters of m6A display reduced replication in A549 cells, primary well differentiated human airway epithelial cultures, and respiratory tracts of cotton rats. One of the m6A-deficient variants is highly attenuated yet retains high immunogenicity in cotton rats. Collectively, our results demonstrate that viral m6A methylation upregulates RSV replication and pathogenesis and identify viral m6A methylation as a target for rational design of live attenuated vaccine candidates for RSV and perhaps other pneumoviruses.
Insights
Viral RNA modification, N6-methyladenosine (m6A), boosts respiratory syncytial virus (RSV) replication and disease. Targeting m6A offers a new strategy for developing live attenuated RSV vaccines.
Area of Science:
- Virology
- Molecular Biology
- Epigenetics
Background:
- N6-methyladenosine (m6A) is a prevalent mRNA modification in eukaryotes.
- The role of m6A in respiratory syncytial virus (RSV) replication and pathogenesis is largely unknown.
Purpose of the Study:
- To investigate the impact of m6A modifications on RSV RNA.
- To determine if m6A influences RSV replication and pathogenesis.
- To explore the potential of targeting viral m6A for vaccine development.
Main Methods:
- Analysis of m6A modification sites in RSV RNAs.
- Manipulation of m6A levels using methyltransferase and demethylase knockdown.
- Generation and characterization of recombinant RSV variants with altered m6A patterns.
- Assessment of viral replication and pathogenesis in cell cultures and animal models.
Main Results:
- RSV RNAs are modified by m6A in specific regions, enhancing viral replication and pathogenesis.
- Decreased m6A levels (via methyltransferase knockdown) reduced RSV replication and gene expression.
- Increased m6A levels (via demethylase knockdown) enhanced RSV replication.
- RSV G gene transcripts exhibit the highest m6A modification.
- RSV variants with reduced m6A in G transcripts showed attenuated replication but retained immunogenicity.
Conclusions:
- Viral m6A methylation is a key regulator of RSV replication and pathogenesis.
- m6A modification of RSV RNA presents a promising target for developing live attenuated vaccines.
- This strategy may be applicable to other pneumoviruses.
Related Concept Videos
Viral Mutations
Viruses with RNA Genomes
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Leaky Scanning
Retrovirus Life Cycles
Mechanisms of Retrovirus-induced Cancers

